We treated control or LTF-depleted U251 and LN229 cells with an increased dose of TMZ, and CCK8 results indicated that LTF knockdown significantly increased the sensitivity of GBM cells to TMZ (Figure 4A). The gene discussed is LTF; the disease is glioblastoma.